Ask AI
HearingHouse

FDA Oversight: Blood Safety and the Implications of Pool Sizes in the Manufacture of Plasma Derivatives

Held

Thursday, July 31, 1997

Held by

House Government Reform Committee

Watch / read on Congress.gov
FDA Oversight: Blood Safety and the Implications of Pool Sizes in the Manufacture of Plasm… — Informed